Related Experiment Video

Updated: Apr 18, 2026

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.4K

Peptide vaccines for cancer therapy

Daniela Cerezo, María J Peña, Michael Mijares

  • 1Inmunologia, Facultad de Medicina, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela. sanctisj@gmail.com.

Recent Patents on Inflammation & Allergy Drug Discovery
|February 3, 2015
PubMed

Insights

Cancer vaccines show promise, but clinical results have lagged. Recent advances in peptide vaccines, adjuvants, and antigen presentation offer new therapeutic strategies for cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Cancer vaccines have been developed for decades with initial promise but limited clinical success.
  • Recent breakthroughs in vaccine technology, including adjuvants, delivery systems, and antigen presentation, are paving the way for novel approaches.

Purpose of the Study:

  • To review peptide vaccines for cancer, focusing on antigen presentation and immune response.
  • To explore cell death pathways and targeted therapy for oncogene mutations relevant to cancer vaccines.

Main Methods:

  • Review of current literature on peptide vaccines in oncology.
  • Analysis of advancements in cancer antigen presentation and immune stimulation.
  • Examination of cell death mechanisms and targeted therapies for oncogenes.

Main Results:

  • Peptide vaccines represent a promising avenue, leveraging specific immune responses against cancer antigens.
  • New patented approaches enhance antigen presentation and immune activation.
  • Targeted therapies for modified oncogenes complement vaccine strategies.

Conclusions:

  • Despite historical challenges, evolving research in peptide vaccines, adjuvants, and antigen presentation holds significant potential for future cancer treatment.
  • Integration of cell death pathways and targeted oncogene therapy may improve vaccine efficacy.

More Related Videos

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.8K
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

10.0K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
62